- Home
- / PsyBio Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PsyBio Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-04-05
Market Capitalization
$1.3 M
2024-04-05
CreditSafe Score
?
Score changed on Jul 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Operating expense total | 52.0K | 19.0K | 6.5M | 2.5M | |
| Depreciation and amortization | 152.0K | ||||
| EBITDA | (52.0K) | (19.0K) | (6.5M) | (2.5M) | |
| EBIT | (52.0K) | (19.0K) | (6.7M) | (2.9M) | |
| Pre tax profit | (52.0K) | (28.0K) | (53.0K) | (11.0M) | (4.9M) |
| Income tax expense | (31.0K) | ||||
| Net Income | (52.0K) | (28.0K) | (22.0K) | (11.0M) | (4.9M) |